Keyphrases
Adaptive Immune Response
25%
Automated Microscopy
25%
CD-8
25%
Cell Density
25%
Chemotherapy
25%
Chemotherapy Efficacy
25%
Chemotherapy-free
25%
Clinical Course
25%
Colorectal Liver Metastases
100%
Conventional Chemotherapy
25%
Density Value
25%
Forkhead Box P3 (FOXP3)
25%
Good Prognosis
25%
Granzyme B
25%
High Density
50%
High-resolution
25%
Human Colorectal Cancer
100%
Immune Cells
100%
Immunohistochemical Staining
25%
In Situ
25%
Invasive Margin
100%
Large Section
25%
Liver Metastasis
25%
Local Immune Response
25%
Long Progression-free Survival
25%
Metastatic Colorectal Cancer (mCRC)
50%
Metastatic Lesions
50%
Precancerous Lesions
25%
Predictive Score
25%
Predictive Tool
25%
Primary Tumor
50%
Prognostic Marker
25%
Prognostic Role
25%
Progression-free Survival
25%
Response Prediction
25%
Response to Chemotherapy
100%
Scoring System
25%
Training Set
25%
Tumor-infiltrating Lymphocytes
100%
Validation Set
25%
Pharmacology, Toxicology and Pharmaceutical Science
CD3 Antigen
14%
CD8 Antigen
14%
Chemotherapy
100%
Colorectal Carcinoma
100%
Disease Course
14%
Granzyme B
14%
Liver Metastasis
100%
Metastatic Colorectal Cancer
28%
Neoplasm
57%
Primary Tumor
28%
Progression Free Survival
28%
Immunology and Microbiology
Adaptive Immune System
16%
CD3 Antigen
16%
CD8
16%
Cell Density
16%
Colorectal Carcinoma
100%
FOXP3
16%
Granzyme B
16%
Immune Response
16%
Immunocompetent Cell
100%
Progression Free Survival
33%
Tissue Section
16%
Tumor-Infiltrating Lymphocytes
66%
Biochemistry, Genetics and Molecular Biology
Adaptive Immunity
25%
CD8
25%
Cell Density
25%
FOXP3
25%
Granzyme B
25%
Immune Response
25%
Immunocompetent Cell
100%
Progression Free Survival
50%
Tissue Section
25%
Tumor-Infiltrating Lymphocytes
100%
Veterinary Science and Veterinary Medicine
Colorectal Cancer
100%
FOXP3
25%
Metastatic Colorectal Cancer
50%
Neoplasm
50%
Tumor-Infiltrating Lymphocytes
100%
Agricultural and Biological Sciences
Adaptive Immunity
16%
Granzyme
16%
Immune Response
16%
Malignant Neoplasm
100%
Neoplasm
33%
Tumor
33%
Tumor-Infiltrating Lymphocytes
66%